Impact of pregnancy on psychoactive substance use among women with substance use disorders recruited in addiction specialized care centers in France

Abstract

Pregnancy can be a motivation for decrease in drug abusing but may also represent a period of high vulnerability for relapse. We aimed to assess psychoactive substance use among women with substance use disorders followed in addiction care centers in France. We analyzed data from women aged 15-44 years included in the 'Observation of illegal drugs and misuse of psychotropic medication (OPPIDUM) survey', an annual cross-sectional survey collecting details on psychoactive substances used. Characteristics of women included in 2005-2012 yearly surveys were compared depending on their pregnant or not pregnant status. Factors, including pregnancy, associated with illicit substance use and medication misuse were investigated through logistic regression. The study included 518 pregnant and 6345 nonpregnant women; 85.3% pregnant women were on opioid maintenance therapy (OMT) (vs. 77.1% of nonpregnant). Pregnancy was associated with lower illicit substance use (adjusted OR 0.71 [0.58-0.88]) and with lower medication misuse (0.66 [0.49-0.89]), whereas financial insecurity and living as a couple were associated with increased risk. Raising children was significantly associated with less risk of substance use. Each substance taken separately, the part of women using illicit substance or misusing medication did not differ depending on whether they were pregnant or not, except for heroin (24.5% in pregnant vs. 17.9% nonpregnant; <0.001). This nationwide study provides new insights into psychoactive substance use in a large mixed population of women with drug use disorders. Results outline the challenge of preventing drug use and initiating care strategies with a specific approach on socio-economic environment.

Discussed Poster Abstracts

“…A decrease in potentially pathogenic members of the Proteobacteria phylum and an increase in some beneficial members of the Firmicutes and Actinobacteria phyla were observed. Discussion/Conclusion: Our preclinical data show that the anti-arthritic effect of tofacitinib is coincident to favourable changes in mucosal immunity and gut microbiota [3]. References: [1] Hodge JA, et al The mechanism of action of tofacitinib -an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis.…”

“…No relationship between NODM and Tac exposure indices (concentrations (C0) or area under the curve (AUC)) has been clearly found [2]. However, cumulative exposure to Tac in the first 3 months appears to be associated to the development of diabetes mellitus [3]. The aim of this study was to develop metrics derived from Tac C0 to assess cumulative exposure to Tac and evaluate its influence on NODM.…”

“…Histologically, the lesions mainly involve architectural disorganization of the digestive epithelium in the most distal portion of the gastrointestinal tract. Recent investigations have highlighted the contribution of intestinal dysbiosis [1] and digestive accumulation of MPA [2,3] in the development of the lesions. To date, the underlying mechanisms are still poorly understood.…”

“…Material and methods: Colitis was induced by dextran sulphate sodium (DSS) in CCR3-deficient mice or in wild-type mice treated with GW766994 (agreement APAFIS 10048-2 017 050 311 316 358). Previous preclinical data from GSK laboratory showed that a systemic injection of 8 mg/kg/d of GW766994, inhibited 99% of CCR3 receptor at 8 hours and 11% at 24 hours, respectively [3]. We therefore administered the CCR3 antagonist daily at 10 mg/kg/d by intraperitoneal injection during DSS exposure (from day 0 to day 7).…”

Identification and tracking of addictovigilance signals in general practice: which interactions between the general practitioners and the French addictovigilance network?

“…The unique situation of France which holds an effective safety monitoring system for drugs with abuse potential and able to identify early signals, must be promoted. Readers of Fundamental and Clinical Pharmacology can find several illustrations of addictovigilance activities in recent issues of the journal . Experience acquired in France and elsewhere has shown that this effectiveness is due to multi‐source approaches and pharmacological expertise.…”